Member Info for Moneymunch

3.8p by close of play by the looks of it Porter, Genflow’s golden tickets are in very high demand. Gl...On and UP!!! :-)

0

It's all about market appreciation Marmie, which certainly appears to be on its way and so fair value on your valuation should quickly follow imho. A 12 month high would take us to £25m, in the meantime Zak Mir's charts are suggesting "3.8p by end of June, if not sooner", which would take us to the lower end of your valuation, although with potential game changing news stacking UP, Genflow’s sp and market cap could be propelled far higher. Full market appreciation of Genflow’s cutting edge science and unique position in the longevity space could potentially be transformational for all invested. Gl :-)

htTps://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-friday-24th-may-2024/

Insignificant negativity here Porter, let the sp do the talking. I can't wait and am so excited about what's ahead. Gl :-)

Yet another 1m late reported buy from yesterday, one of the many over the last week or so, suggests big players have a significant interest in Genflow’s upside potential, as if today's performance wasn't a strong indication of bigger and better things to come. Watch this space and/or buy as many shares you can imho, Genflow and its shareholders are all set for a stellar rise, regardless of the opinion if those with no money and obviously no shares. Gla holders , long live longevity!!! :-)))

Every chance Porter, right time, right place and just the start of a stellar journey ahead and hoping we have a Major JV partner in the frame who wants on early on Genflow’s cutting edge science and multi-billion dollar potential of Sirt6's potency in the longevity space and multiple disease targets. Gl :-))))

Happy Days!!! Genflow is all set for some serious UPside, 12 month high coming soon!!! Gla holders On and UP!!! :-)))

On and UP!!! Exciting times!!! Gla :-)

“Helping create these connections is central to our mission at Founders Forum Group as we seek to empower entrepreneurs at every stage of their journeys; with Longevity.Technology as our partner, we can forge formative alliances that propel longevity innovation.”

Key highlights of the Founders Longevity Forum:

Exclusive event – The Founders Longevity Forum will host a minimum of 120 approved guests, including high-caliber investors, family offices, longevity founders and VIPs.

Comprehensive program – guests will enjoy a half-day of content, a welcome reception, a full-day program and automatic registration for London Tech Week.

Global reach – following the London event, the Founders Longevity Forum will travel to Abu Dhabi and San Francisco.

Longevity takes center stage – The Longevity Village at London Tech Week will elevate this dynamic industry, showcasing the companies applying new technologies to extend human healthspan.

htTps://longevity.technology/news/founders-forum-and-longevity-technology-join-forces-to-accelerate-longevity-investment/

10th - 11th June 2024 - Organised by Longevity Technology who hold 3% of Genflow, the advisory panel includes Eric Verdin who sits on Genflow's Scientific Advisory Board, Aubrey de Grey who originally was a member of Genflow's SAB and Jim Mellon who was an inestor in Genflow's IPO....All bodes well!!! Gla ;-)

New international event program launches to bring longevity entrepreneurs and investors together.

Founders Forum and Longevity.Technology today announced the launch of the Founders Longevity Forum, a premier event series designed to educate and connect investors with the vast potential within the longevity market.

The inaugural Founders Longevity Forum will take place at Olympia London during the renowned London Tech Week, focusing on a sector that is projected to exceed $600 billion by 2025. This partnership aims to foster meaningful connections between startups, venture capitalists (VCs), corporate venture capitalists (CVCs), family offices and CEOs leading the charge in longevity.

Brent Hoberman, Co-Founder and Executive Chair of Founders Forum Group, said: “Longevity is becoming a mega trend as science makes increased healthspans more realistic, converging with a wider shift towards preventative healthcare.

“We’ve noticed a need to connect top scientists and innovative startups with funds to help them turn their dreams into reality. By bringing together the best and brightest minds working on longevity today, we can galvanize progress in this area and transform the demographic landscape.”

Taking place on New international event program launches to bring longevity entrepreneurs and investors together.4, the Founders Longevity Forum will address the investment opportunities across the longevity space, from established longevity business models such as diagnostics, longevity clinics and supplements, through to cutting-edge longevity biotech companies poised to revolutionize the biotech industry and transform society.

The event will also benefit from an advisory panel that has decades of longevity and geroscience expertise between them; the panel includes Eric Verdin, Andrea Maier, Jim Mellon and Aubrey de Grey, with further members to be announced.

“Multiple longevity events are happening and they’re all great, but few are specifically focused on bringing more investors into this rapidly accelerating field,” said Phil Newman, Founder and CEO, Longevity.Technology.

“We plan to stage events in London, Abu Dhabi and San Francisco initially to accelerate longevity investment globally, and catalyze a wave of innovation and collaboration that will redefine the future of human health.”

“We’re keen to educate investors on the vast opportunities in longevity whilst fostering meaningful connections for startups and scaleups in this niche,” said Carolyn Dawson, CEO, Founders Forum Group.

We've hit a 6 month high and every chance we'll hit a 12 month high as good news is delivered by Eric and the team. Momentum building, excitement building. Genflow has the potential and prospects to be the stand out share for 2024 and beyond!!! Gla holders:-)

Genflow Biosciences (LON:GENF) (OTCQB:GENFF)

1,611 followers

5h

At Genflow Biosciences (LON:GENF) (OTCQB:GENFF), our research focuses on the #SIRT6 gene which may hold the key to extending the #healthspan of humans and their canine companions.

A mutation known as "#Centenarian SIRT6" could be crucial for developing new treatments. The following highlights underscore our unique position:

✅ immense global market with few competing treatments

✅ impressive, long life IP for both gene & gene delivery

✅ key clinical and regulatory milestones expected in next 18 months

Learn more about #GENF's cutting edge work here: hTtps://loom.ly/MeQymHs

An anti ageing research company based in London | Genflow

The smart Money is accumulating as the free float gets squeezed with the majority of shares held very tightly. Positive newsflow could drop at anytime on multiple fronts including confirmation of the payment of €770k from the €2.89m grant, expected imminently, which should be very well received. Game changing news also possible judging by the re-rate in progress....they want your shares!!! Gla :-)

Cheers Porter, cutting edge science with patents pending, compelling preclinical data progressing to human clinical trials, prestigious academic partners and a leading influential and distinguished hands on Scientific Advisory Board.

Exponential upside potential and prospects!!! Gl :-)

This coming week could be exciting imho, continued UPward momentum very likely as the next UPdate on proceedings gets closer. Game changing news at anytime on clinical progress, US institutional investors, JV partner and or additional grant funding from the likes of the Hevolution Foundation, the Saudi organisation who have an annual $1 billion dollar investment fund into the longevity space, who appear to have close links to Eirc Verdin, a highly respected and leading scientist who sits on Genflow’s Scientific Advisory Board. Hevolution invested $20m into the Buck Institute end of last year, where Eric Verdin is the CEO and invested a further $20m last month into Aeovian, who just so happen to be founded by the Buck Institute. Hopefully the share accumulation that's been in progress are by those who know more than us and yet are just as excited by the enormous potential ahead. Gla :-)

htTps://www.buckinstitute.org/news/buck-founded-aeovian-pharmaceuticals-doses-first-participants-in-phase-i-trial/

.....

18th May 2024

htTps://www.thenationalnews.com/news/uae/2024/05/18/longevity-focus-should-be-on-good-health-not-just-lifespan-saudi-health-chief-says/

Big buys being filled!!!??? Gl :-)

As "positive newsflow is delivered "....expected imminently!!! :-)

Very nice indeed Porter, we're looking good and strong for a significant re-rate as positive n. Gl :-)

Another big day on the cards, with any luck. The majority of shares are now very tightly held for better and bigger things to come, and so plenty of UPside momentum from now on in, from those who want in, including the bigger players who are accumulating for the significant re-rate ahead!!! Gl :-)

The Business Case for Longevity

·May 2024 ·

Longevity is the biggest market in the world.

The ROI is huge, almost too big to see. Many people also don’t realize that longevity businesses are critical for the future of humanity.

https://www.nfx.com/post/business-case-for-longevity

Got a feeling the free float has been mopped UP!!! :-)